BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22985810)

  • 21. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy in the geriatric population.
    Green JM; Hacker ED
    Clin J Oncol Nurs; 2004 Dec; 8(6):591-7. PubMed ID: 15637954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
    DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
    Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of age and comorbidities on the treatment of gastrointestinal malignancies.
    Wo JY; Hong TS; Kachnic LA
    Semin Radiat Oncol; 2012 Oct; 22(4):311-20. PubMed ID: 22985814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External audit of clinical practice and medical decision making in a new Asian oncology center: results and implications for both developing and developed nations.
    Shakespeare TP; Back MF; Lu JJ; Lee KM; Mukherjee RK
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):941-7. PubMed ID: 16297568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
    Dahm P; Yeung LL; Chang SS; Cookson MS
    J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivorship: adult cancer survivors.
    Ganz PA
    Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends in the management of potentially resectable lung cancer.
    Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
    Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
    Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
    Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy in the elderly: how and for whom?].
    Avenin D; Selle F; Gligorov J; Japkowicz M; Houssel P; Carette B; Bernard M; Abbas F; Khalil A; Bourayou N; Lokiec F; Carola E; Saint-Jean O; Leblond V; Bouvard E; Lotz JP
    Bull Cancer; 2008 May; 95 FMC Onco():F28-36. PubMed ID: 18511364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating a geriatric evaluation in the clinical setting.
    Extermann M
    Semin Radiat Oncol; 2012 Oct; 22(4):272-6. PubMed ID: 22985809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC).
    Firat S; Pleister A; Byhardt RW; Gore E
    Am J Clin Oncol; 2006 Jun; 29(3):252-7. PubMed ID: 16755178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical review of the management of early-stage breast cancer in elderly women.
    Passage KJ; McCarthy NJ
    Intern Med J; 2007 Mar; 37(3):181-9. PubMed ID: 17316337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.